Analyst Ratings for AzurRx Biopharma (AZRX) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/24/2020 | Roth/MKM » Updated 4/1/2021 |
Jonathan Aschoff | New Coverage | Buy (N/A) |
5.00 (7.00) |
1.08 (3.45) |
219.44% | Details |
| 6/11/2019 | National Securities | Jonathan Aschoff | New Coverage | Buy (N/A) |
9.00 (N/A) |
2.05 (3.45) |
68.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
